IFP Advisors’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.4K Hold
96
﹤0.01% 3894
2025
Q4
$2.53K Hold
96
﹤0.01% 3744
2025
Q3
$1.64K Hold
96
﹤0.01% 3774
2025
Q2
$1.21K Buy
+96
New +$1.14K ﹤0.01% 4150
2025
Q1
Hold
0
4032
2024
Q4
Hold
0
4213
2023
Q3
Sell
-300
Closed -$2.59K 3577
2023
Q2
$2.59K Hold
300
﹤0.01% 2790
2023
Q1
$1.47K Sell
300
-300
-50% -$2.62K ﹤0.01% 2987
2022
Q4
$8K Buy
600
+300
+100% +$2.11K ﹤0.01% 3562
2022
Q3
$7K Hold
300
﹤0.01% 3891
2022
Q2
$7K Hold
300
﹤0.01% 3638
2022
Q1
$7K Hold
300
﹤0.01% 3637
2021
Q4
$5K Hold
300
﹤0.01% 2522
2021
Q3
$9K Buy
300
+225
+300% +$7.48K ﹤0.01% 2340
2021
Q2
$3K Hold
75
﹤0.01% 2675
2021
Q1
$2K Buy
+75
New +$3.05K ﹤0.01% 2729

Other funds holding ZYME

IFP Advisors's ZYME Position: Q1 2026 in Review

IFP Advisors held its Zymeworks (ZYME) position steady in Q1 2026 at 96 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3894.

IFP Advisors first reported a position in ZYME in Q1 2021 and has held it in 14 quarters since. The position peaked at $9K in Q3 2021. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • IFP Advisors held 96 shares of Zymeworks worth $2.4K as of Q1 2026.
  • IFP Advisors left its Zymeworks share count unchanged in Q1 2026.
  • Zymeworks made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #3894 holding.
  • IFP Advisors first reported a position in Zymeworks in Q1 2021 and has held it in 14 quarters since.
  • IFP Advisors's Zymeworks position peaked at $9K in Q3 2021.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.